Sandoz, the Novartis generic and biosimilar pharmaceutical division, announces the launch of Sandoz HACk - Healthcare Access Challenge - a global competition to generate innovative ideas and solutions to help tackle some of the world's most pressing healthcare access problems. The competition is open for entries until November 30, 2016. 
Accenture has announced the creation of the Accenture HealthTech Innovation Challenge which brings together leading-edge startups with prominent life sciences and health companies to tackle some of the world's greatest health challenges including access, affordability and transparency. 
Royal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., have announced a strategic technology collaboration to advance connected health across the health continuum - from healthy living and prevention to chronic care management and home care. 
The U.S. Food and Drug Administration has announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. The FDA, with support from the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), is inviting computer programmers, public health advocates, clinical researchers, entrepreneurs and innovators from all disciplines to Royal Philips (NYSE: PHG, AEX: PHIA) has unveiled its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which was held in Barcelona (Spain) from September 10 until 14. Philips' next generation interventional oncology solution OncoSuite will enable physicians to provide analysis and minimally invasive, targeted treatment of tumor lesions reducing the impact to healthy tissue. 
Pfizer Inc. (NYSE:PFE) has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health disorders in the United States, as an estimated one in 15 adults (6.7%) experience at least one major depressive episode in any given year. 
Sanofi and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company, have announced the launch of Onduo, a joint venture created through Sanofi and Verily's diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge. Onduo's mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management.